United States Market Monthly Performance for March 2022

Monthly Gainers
2,627
Monthly Losers
2,297
Average Return
10.18%
Total Stocks
5,066
View Detailed Market Cap Breakdown
Market CapMonthly GainersMonthly LosersAverage ReturnTotal Stocks
Mega Cap 28 18 3.11% 47
Large Cap 443 247 2.40% 691
Mid Cap 448 460 1.35% 921
Small Cap 237 231 0.20% 475

Monthly Streak Leaders for March 2022

Stock Streak Streak Return
6 months โ†‘ 49.76%

AbbVie shows consistent strength with a 6-month winning streak (108.25 โ†’ 162.11), delivering 49.8% gains. With 13.3B revenue generating only 1.3B profit (9.7% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

4 months โ†‘ 41.65%

Chevron gains traction with a 4-month winning streak (114.95 โ†’ 162.83), delivering 41.7% gains. With 46.1B revenue generating only 3.5B profit (7.6% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

5 months โ†“ -45.64%

Netflix navigates difficult waters with a 5-month decline (689.06 โ†’ 374.59), down 45.6%. However, fundamentals remain robust: 10.5B revenue generating 2.9B profit (27.4% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note.

5 months โ†“ -20.76%

JPMorgan Chase encounters challenges with a 5-month decline (172.04 โ†’ 136.32), down 20.8%. Weak margins on 45.3B revenue with only 14.6B profit (32.3% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

6 months โ†‘ 53.19%

McKesson shows consistent strength with a 6-month winning streak (199.84 โ†’ 306.13), delivering 53.2% gains. With 90.8B revenue generating only 1.3B profit (1.4% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

6 months โ†‘ 35.73%

Corteva builds on success with a 6-month winning streak (42.35 โ†’ 57.48), delivering 35.7% gains. The financials tell a compelling story: 4.4B revenue generating 656.0M net profit (14.9% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

9 months โ†“ -69.00%

Pinterest faces persistent headwinds with a 9-month decline (79.39 โ†’ 24.61), down 69.0%. Weak margins on 855.0M revenue with only 8.9M profit (1.0% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

9 months โ†“ -58.38%

Twilio faces persistent headwinds with a 9-month decline (396.00 โ†’ 164.81), down 58.4%. Weak margins on 1.2B revenue with only 20.0M profit (1.7% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

7 months โ†‘ 228.06%

Irhythm Technologies maintains strong momentum with a 7-month winning streak (48.00 โ†’ 157.47), delivering 228.1% gains. Despite 158.7M in revenue and - 30.7M loss (-19.3% margin) as of Qtr ending Mar 2025, the market sees potential beyond current profitability. This momentum suggests confidence in future execution.

6 months โ†‘ 60.53%

Adma Biologics builds on success with a 6-month winning streak (1.14 โ†’ 1.83), delivering 60.5% gains. The financials tell a compelling story: 114.8M revenue generating 26.9M net profit (23.4% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

9 months โ†“ -80.50%

Recursion struggles to find footing after a 9-month decline (36.72 โ†’ 7.16), down 80.5%. Financial struggles compound the decline: despite 14.8M revenue, - 202.5M losses persist (-1366.5% margin) as of Qtr ending Mar 2025. Until profitability improves, caution remains warranted.

8 months โ†“ -40.02%

SolarWinds experiences extended pressure with a 8-month decline (22.19 โ†’ 13.31), down 40.0%. However, fundamentals remain robust: 210.3M revenue generating 72.7M profit (34.6% margin) as of Qtr ending Dec 2024 suggests this could be a temporary setback. Value hunters take note.

8 months โ†‘ 210.82%

Liquidia shows consistent strength with a 8-month winning streak (2.31 โ†’ 7.18), delivering 210.8% gains. Despite 3.1M in revenue and - 38.4M loss (-1229.7% margin) as of Qtr ending Mar 2025, the market sees potential beyond current profitability. This momentum suggests confidence in future execution.

6 months โ†‘ 17.87%

Stellar Bancorp maintains strong momentum with a 6-month winning streak (26.30 โ†’ 31.00), delivering 17.9% gains. With 108.0M revenue generating only 25.2M profit (23.3% margin) in Qtr ending Dec 2024, the market prices in future margin expansion potential.

9 months โ†“ -88.68%

Ars Pharmaceuticals faces persistent headwinds with a 9-month decline (31.01 โ†’ 3.51), down 88.7%. Financial struggles compound the decline: despite 8.0M revenue, - 33.9M losses persist (-425.7% margin) as of Qtr ending Mar 2025. Until profitability improves, caution remains warranted.

7 months โ†“ -81.31%

PLSE faces significant headwinds with 7 consecutive negative months, down 81.31%.

United States Market Monthly Gainers & Losers: March 2022

Top United States Stock Gainers (March 2022)

StockMonth OpenMonth CloseMonthly ChangeAvg Daily VolumeMonth Volume
$289.89 $359.20 23.80% 78.60M 1.73B
$11.99 $13.73 15.86% 46.16M 1.02B
$247.56 $286.37 14.57% 3.21M 70.54M
$145.01 $162.83 13.08% 23.98M 527.49M
$24.29 $27.29 11.89% 529.30M 11.64B
$23.52 $34.41 48.70% 11.34M 249.51M
$7.10 $9.98 40.96% 3.86M 84.95M
$27.49 $37.74 38.70% 22.49M 494.82M
$25.71 $35.31 36.12% 5.00M 110.04M
$30.55 $41.65 35.10% 28.94M 636.57M
$3.58 $6.62 95.28% 1.99M 43.73M
$139.84 $228.80 63.62% 50.48K 1.11M
$4.09 $4.67 58.84% - -
$8.45 $13.05 57.23% 4.02M 88.42M
$3.13 $4.81 52.70% 2.43M 53.47M
$2.92 $4.18 44.14% 4.25M 93.58M
$5.78 $8.24 42.56% 549.16K 12.08M
$17.91 $24.53 41.46% 14.70M 323.42M
$2.64 $3.68 40.46% 3.23M 71.08M
$5.57 $7.82 39.64% 160.92K 3.54M

Biggest United States Stock Losers (March 2022)

StockMonth OpenMonth CloseMonthly ChangeAvg Daily VolumeMonth Volume
$122.33 $109.34 -11.35% 111.83M 2.46B
$52.44 $48.46 -9.20% 34.30M 754.69M
$147.86 $137.16 -7.61% 10.26M 225.74M
$101.07 $93.94 -7.05% 7.40M 162.87M
$43.71 $41.22 -6.74% 59.67M 1.31B
$36.40 $21.40 -40.90% 17.64K 388.10K
$5.62 $3.50 -39.24% 28.39M 624.50M
$65.60 $40.68 -38.13% 5.08M 111.77M
$20.00 $12.37 -36.27% 33.07M 727.57M
$26.44 $17.68 -33.33% 15.78M 347.17M
$3.05 $1.79 -41.88% 30.95M 680.84M
$35.00 $21.59 -37.80% 7.95M 174.94M
$10.02 $6.30 -36.43% 456.53K 10.04M
$10.78 $7.16 -34.61% 1.54M 33.87M
$160.00 $109.09 -30.95% 14.84M 326.47M
$11.06 $11.05 -55.44% - -
$0.50 $0.23 -53.06% 6.85K 150.70K
$6.88 $3.43 -49.56% 1.71M 37.53M
$1.41 $0.77 -47.97% 78.22K 1.72M
$5.41 $2.96 -45.19% 3.24M 71.35M

Most Active United States Stocks During March 2022

StockMonth OpenMonth CloseMonthly ChangeAvg Daily VolumeMonthly Volume
$24.29 $27.29 11.89% 529.30M 11.64B
$122.33 $109.34 -11.35% 111.83M 2.46B
$164.70 $174.61 5.75% 99.13M 2.18B
$22.56 $21.05 -7.84% 96.10M 2.11B
$17.41 $16.91 -3.70% 79.52M 1.75B
$289.89 $359.20 23.80% 78.60M 1.73B
$152.73 $163.00 6.15% 74.02M 1.63B
$11.96 $9.45 -17.47% 64.65M 1.42B
$44.33 $56.74 29.75% 56.60M 1.25B
$16.97 $18.25 5.80% 54.90M 1.21B
$19.97 $20.22 -0.54% 43.46M 956.13M
$47.54 $49.56 3.90% 38.60M 849.29M
$3.59 $4.57 29.10% 38.03M 836.56M
$3.05 $1.79 -41.88% 30.95M 680.84M
$22.59 $32.21 44.05% 29.09M 639.97M
$25.30 $28.61 13.13% 22.36M 491.87M
$2.75 $3.55 30.51% 16.45M 361.98M
$17.91 $24.53 41.46% 14.70M 323.42M
$1.55 $1.60 7.38% 14.08M 309.81M
$8.58 $6.57 -23.16% 12.81M 281.87M

United States Sector Performance During March 2022

Healthcare

37.12%
1073 stocks
Top Performers by Market Cap:
Mega Cap: LLY +14.57%
Large Cap: DXCM +23.60%
Small Cap: MNKD +40.46%

Energy

14.65%
187 stocks
Top Performers by Market Cap:
Mega Cap: CVX +13.08%
Large Cap: EQT +48.70%
Small Cap: BTU +41.46%

Basic Materials

11.19%
244 stocks
Top Performers by Market Cap:
Mega Cap: LIN +8.93%
Large Cap: X +38.70%
Mid Cap: TMC +49.71%
Small Cap: AMR +39.23%

Utilities

7.06%
90 stocks
Top Performers by Market Cap:
Large Cap: CEG +22.34%
Mid Cap: AES +21.20%
Small Cap: ARIS +24.57%

Industrials

3.94%
583 stocks
Top Performers by Market Cap:
Mega Cap: GE -4.18%
Large Cap: VRSK +21.03%
Small Cap: EOSE +44.14%

Real Estate

3.34%
252 stocks
Top Performers by Market Cap:
Large Cap: WELL +15.43%
Mid Cap: IVT +18.61%
Small Cap: BFS +14.49%

Consumer Cyclical

1.99%
519 stocks
Top Performers by Market Cap:
Mega Cap: TSLA +23.80%
Large Cap: GME +35.10%
Mid Cap: JWN +30.71%
Small Cap: ARHS +27.40%

Technology

1.48%
701 stocks
Top Performers by Market Cap:
Mega Cap: PLTR +15.86%
Large Cap: ASTS +40.96%
Small Cap: BBAI +42.56%

Consumer Defensive

1.29%
206 stocks
Top Performers by Market Cap:
Mega Cap: COST +10.90%
Large Cap: KR +22.59%
Small Cap: ASAI +31.65%

Communication Services

1.02%
229 stocks
Top Performers by Market Cap:
Mega Cap: META +5.37%
Large Cap: FWONK +15.01%
Small Cap: GOGO +33.85%

Financial Services

-0.81%
843 stocks
Top Performers by Market Cap:

Data is updated regularly. Monthly performance is calculated based on closing prices.